The Best Nasdaq Stocks to Buy for Long-Term Upside The best Nasdaq stocks to buy include familiar tech-related names, as well as companies with strong long-term upside potential operating in other sectors. Kiplinger · Jun 19
Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops These three stocks are down big after earnings, but price targets rose anyway. Updated forecasts now see nearly 50% upside in two mid-cap chip stocks. MarketBeat · Nov 10, 2025
Stocks Turn Lower on Stagflation Fears The S&P 500 Index ($SPX ) (SPY ) today is down -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.16%. March E-mini S&P futures (ESH25 ) are down -0.20%, and March E-mini Nasdaq futures... Barchart · Mar 3, 2025
Positive Corporate News Supports Stocks Ahead of Tuesday's Tariff News The S&P 500 Index ($SPX ) (SPY ) today is down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.20%. March E-mini S&P futures (ESH25 ) are up +0.05%, and March E-mini Nasdaq futures... Barchart · Mar 3, 2025
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022 Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period. Benzinga · May 25, 2022